Doximity, Inc. $DOCS Shares Purchased by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC

Key Points

• UBS AM increased its stake in Doximity, Inc. by 130.4%, owning 1,966,801 shares valued at approximately $114.1 million.
• Insider trading activity included sales by Directors Timothy S. Cabral and Kira Scherer Wampler, reducing their positions by 61.12% and 10.74% respectively.
• Doximity reported a 15.2% increase in revenue year-over-year and earnings per share of $0.36, surpassing analysts' expectations of $0.31.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 130.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,966,801 shares of the company's stock after purchasing an additional 1,113,076 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 1.05% of Doximity worth $114,133,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Amalgamated Bank lifted its holdings in shares of Doximity by 0.3% during the 1st quarter. Amalgamated Bank now owns 60,928 shares of the company's stock worth $3,536,000 after acquiring an additional 186 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock worth $2,262,000 after acquiring an additional 210 shares during the period. Greenleaf Trust lifted its holdings in shares of Doximity by 5.4% during the 1st quarter. Greenleaf Trust now owns 4,492 shares of the company's stock worth $261,000 after acquiring an additional 230 shares during the period. Spire Wealth Management lifted its holdings in shares of Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after acquiring an additional 260 shares during the period. Finally, Allworth Financial LP lifted its holdings in shares of Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after acquiring an additional 287 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on DOCS shares. Piper Sandler increased their price objective on shares of Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. JPMorgan Chase & Co. cut their price objective on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a report on Tuesday, May 27th. Bank of America increased their target price on shares of Doximity from $55.00 to $62.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. KeyCorp increased their target price on shares of Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Finally, Wells Fargo & Company increased their target price on shares of Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research report on Monday, August 4th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $67.00.

Doximity Trading Up 2.1%

NASDAQ:DOCS traded up $1.46 during trading hours on Monday, hitting $72.49. The stock had a trading volume of 1,680,530 shares, compared to its average volume of 2,220,993. Doximity, Inc. has a 1-year low of $39.27 and a 1-year high of $85.21. The business has a 50 day simple moving average of $63.84 and a two-hundred day simple moving average of $59.78. The company has a market cap of $13.58 billion, a PE ratio of 72.49, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the prior year, the business earned $0.28 earnings per share. Doximity's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Insider Transactions at Doximity

In other news, Director Regina M. Benjamin sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $63.00, for a total transaction of $315,000.00. Following the completion of the sale, the director owned 16,618 shares of the company's stock, valued at approximately $1,046,934. This trade represents a 23.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director directly owned 16,618 shares of the company's stock, valued at $948,721.62. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 32,000 shares of company stock valued at $1,929,380. 31.30% of the stock is currently owned by corporate insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.